Disease: Chronic Active Epstein Barr Virus Infection
- <em>Helicobacter pylori</em>-associated Chronic Atrophic Gastritis and Progression of Gastric Carcinogenesis
- A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry
- A glance on the role of IL-35 in systemic lupus erythematosus (SLE)
- A successful treatment for chronic active Epstein-Barr virus disease with Nephrotic Syndrome
- Acyclovir as a Novel Treatment for Severe Chronic Active Epstein-Barr Virus
- An Easily Overlooked Disease: Hemophagocytic Syndrome
- Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders
- ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice
- Antiviral Potential of the Genus <em>Panax</em>: An updated review on their effects and underlying mechanism of action
- Association between serological indicators of past contacts with Herpesviridae and a slower resolution of chronic spontaneous urticaria in children
- Association of SH2 domain-containing protein 1A, immunoglobulins and T lymphocyte subsets with Epstein- Barr virus infections
- Bioinformatics analysis to screen the key genes in pediatric Chronic Active Epstein-Barr Virus Infection
- Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics
- Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma
- Characteristics of plasma Epstein-Barr virus DNA in children with primary infection
- Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population
- Cholecystitis and Cardiomyopathy in an Immunocompetent Patient With Cytomegalovirus Infection: A Case Report
- Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells
- Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells
- Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry - a diagnostic report
- Chronic active Epstein-Barr virus infection mimicking tuberculosis - A diagnostic enigma
- Chronic active Epstein-Barr virus infection with reinfection of SARS-CoV-2: a case report
- Chronic HIV-1 Tat action induces HLA-DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV
- Ciwujianoside E inhibits Burkitt lymphoma cell proliferation and invasion by blocking ENO1-plasminogen interaction and TGF-beta1 activation
- Clinical characteristics and literature review of chronic active Epstein-Barr virus-associated enteritis
- Clinical characteristics of peripheral lymphocyte subtypes in chronic active Epstein-Barr virus infection
- Clinical Characteristics of Peripheral Lymphocyte Subtypes in Chronic Active Epstein-Barr Virus Infection
- Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders
- Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis
- Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells
- Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis
- Coronary Artery Bypass Grafting for a Young Female Patient With Chronic Active Epstein-Barr Virus Infection
- Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
- Cytokine Storm Syndromes Associated with Epstein-Barr Virus
- Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop
- Deciphering the Relationship between SARS-CoV-2 and Cancer
- Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes
- Diagnosis and management of EBV-positive lymphoproliferative disorders
- Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy
- Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation
- Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma
- Electrodiagnostic Evaluation of Acute Inflammatory Demyelinating Polyneuropathy
- Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease
- Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent viruses
- Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
- Epstein-Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report
- Epstein-Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge
- Establishment of Epstein-Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
- Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis
- Friends and Foes in Alzheimer's Disease
- Gastric Cancer in the Era of Epigenetics
- Guillain-Barre syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation
- Helicobacter pylori-associated Chronic Atrophic Gastritis and Progression of Gastric Carcinogenesis
- Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH
- Homozygous variant in TKFC abolishing triokinase activities is associated with isolated immunodeficiency
- Immediate Hypersensitivity Reactions
- Immediate Hypersensitivity Reactions (Archived)
- Immunity and Immune Evasion Mechanisms of Epstein-Barr Virus
- Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody
- Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis
- Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease
- Infectious Diseases and Basal Ganglia Calcifications: A Cross-Sectional Study in Patients with Fahr's Disease and Systematic Review
- Infectious Mononucleosis: An Updated Review
- INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS
- Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection
- Kidney involvement of chronic active Epstein-Barr virus infection
- l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection
- Left ventricular apical aneurysm in Takayasu arteritis and chronic active Epstein-Barr virus infection
- Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
- Lymphocytes in Patients with Chronic Active Epstein-Barr Virus Disease Exhibited Elevated PD-1/PD-L1 Expression and a Prevailing Th2 Immune Response
- Mitochondrial DNA Missense Mutations ChrMT: 8981A > G and ChrMT: 6268C > T Identified in a Caucasian Female with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Triggered by the Epstein-Barr Virus
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A preliminary survey among patients in Switzerland
- Natural killer cell memory precedes HLH in monozygotic twins discordant for chronic active Epstein-Barr virus disease
- Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases
- Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis
- Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
- PD-1 Blockade-Induced Hemophagocytic Lymphohistiocytosis, a Dilemma Therapeutic Outcome in 2 Patients with CAEBV: A Case Series
- PD-1 inhibitor in chronic active Epstein-Barr virus infection: a report of six cases and literature review
- Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study
- Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
- Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy
- Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study
- Quantification of low-level Cytomegalovirus and Epstein-Barr virus DNAemia by digital PCR
- Quantification of low-level human cytomegalovirus and Epstein-Barr virus DNAemia by digital PCR
- Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome
- Recombinant protein EBI3 attenuates Clonorchis sinensis-induced liver fibrosis by inhibiting hepatic stellate cell activation in mice
- Research progress on systemic chronic active Epstein-Barr virus disease
- Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency
- Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection
- Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children
- Synthesis and Pro-Apoptotic Effects of Nitrovinylanthracenes and Related Compounds in Chronic Lymphocytic Leukaemia (CLL) and Burkitt's Lymphoma (BL)
- T cell-mediated immunity during Epstein-Barr virus infections in children
- The effects of urolithin A on poly I:C-induced microglial activation
- The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection
- The whole-blood Epstein-Barr virus DNA can serve as a valuable molecular marker for diagnosis and prognosis prediction of nasopharyngeal carcinoma
- Transplantation in Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Yes or No?
- Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV() Active Ingredients
- Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV<sup>®</sup> Active Ingredients
- Updated guidelines for chronic active Epstein-Barr virus disease